- Filed
- Mar 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 27, 2025 | 1.39M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 466.1K sh |
| Capex | FY 2024 · Dec 31, 2023 | $2.71K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$5.17M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $28.66M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $4.28M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $5.53M |
| Current Assets | FY 2024 · Dec 31, 2023 | $30.53M |
| Total Assets | FY 2024 · Dec 31, 2023 | $31.11M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | $29.56 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | $29.56 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $6.34M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $1.97M |
| Net Income | FY 2024 · Dec 31, 2023 | −$6.04M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $32.69M |